Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

HKG:2563 Statistics

Total Valuation

HKG:2563 has a market cap or net worth of HKD 1.41 billion. The enterprise value is 901.21 million.

Market Cap	1.41B
Enterprise Value	901.21M

Important Dates

The next estimated earnings date is Thursday, June 4, 2026.

Earnings Date	Jun 4, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2563 has 364.59 million shares outstanding. The number of shares has increased by 4.11% in one year.

Current Share Class	216.72M
Shares Outstanding	364.59M
Shares Change (YoY)	+4.11%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	13.34%
Owned by Institutions (%)	14.69%
Float	172.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.90
PB Ratio	1.90
P/TBV Ratio	1.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.16
EV / Sales	24.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.16

Financial Position

The company has a current ratio of 8.33, with a Debt / Equity ratio of 0.00.

Current Ratio	8.33
Quick Ratio	7.53
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-3,014.46

Financial Efficiency

Return on equity (ROE) is -18.04% and return on invested capital (ROIC) is -11.95%.

Return on Equity (ROE)	-18.04%
Return on Assets (ROA)	-10.34%
Return on Invested Capital (ROIC)	-11.95%
Return on Capital Employed (ROCE)	-19.81%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	277,075
Profits Per Employee	-1.09M
Employee Count	131
Asset Turnover	0.04
Inventory Turnover	0.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.47%
50-Day Moving Average	4.06
200-Day Moving Average	4.99
Relative Strength Index (RSI)	34.35
Average Volume (20 Days)	21,900

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2563 had revenue of HKD 37.13 million and -146.26 million in losses. Loss per share was -0.40.

Revenue	37.13M
Gross Profit	34.21M
Operating Income	-155.35M
Pretax Income	-146.26M
Net Income	-146.26M
EBITDA	-144.80M
EBIT	-155.35M
Loss Per Share	-0.40

Balance Sheet

The company has 508.29 million in cash and 2.20 million in debt, with a net cash position of 506.10 million or 1.39 per share.

Cash & Cash Equivalents	508.29M
Total Debt	2.20M
Net Cash	506.10M
Net Cash Per Share	1.39
Equity (Book Value)	741.22M
Book Value Per Share	2.03
Working Capital	566.00M

Cash Flow

In the last 12 months, operating cash flow was -168.61 million and capital expenditures -6.03 million, giving a free cash flow of -174.64 million.

Operating Cash Flow	-168.61M
Capital Expenditures	-6.03M
Depreciation & Amortization	10.96M
Net Borrowing	n/a
Free Cash Flow	-174.64M
FCF Per Share	-0.48

Margins

Gross Margin	92.13%
Operating Margin	-418.41%
Pretax Margin	-393.94%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2563 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.11%
Shareholder Yield	-4.11%
Earnings Yield	-10.39%
FCF Yield	-12.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2563 has an Altman Z-Score of 14.97 and a Piotroski F-Score of 1.

Altman Z-Score	14.97
Piotroski F-Score	1